Sentro Group come up with new Vertical focused on Pharma & Healthcare

SentroGroup has been diversifying into several different industries over the past three decades and now it is leveraging its strengths in aviation, real estate and tourism with the addition of a new vertical focused on pharmaceuticals and healthcare. End Quote

(1888PressRelease) February 15, 2023 - New Delhi, Delhi - Sentro Group, a global leader in innovative technology solutions, announced today the launch of its new vertical Sentro Pharma, that aims to bring innovation and creativity to the Pharmaceutical Industry by marketing drugs like never before, designed specifically for Pharma and Healthcare Industries. This new business vertical will provide customers with a range of high-quality pharmaceutical products and services that meet the needs of patients and healthcare providers.

Sentro Pharma is the result of extensive research and development, and its cutting-edge
features are designed to meet the needs of the pharmaceutical industry. Its creativity in tackling new challenges, use of big data in drug development for precision medicine, a higher quality cell-based phenotypic screening method to integrate existing components of various illnesses, for example, inflammation, digestion, metabolic, and infectious diseases, in order to treat multiple dysfunction pathways and delivering high quality products to medical fraternity at affordable price, makes it stand out from the competition and provide customers with a unique experience.

"We are excited to announce the launch of Sentro Pharma," said Dr. Naveen Rao, Chairman & Founder of Sentro Group. "This new business vertical is the result of our commitment to
innovation and customer service, and we believe that it will provide our customers with a range of benefits that will enhance their healthcare experience."

Sentro Pharma will offer a range of pharmaceutical products and services, which will be
available for purchase through our website and authorised dealers. The company will also be
offering a range of training and support services to help customers get the most out of their new products.

The Sentro Pharma will provide you following list of products those categorised into 3
therapeutic categories which are Diabetes, Cardiology, and Multivitamins:

Cipsen 20mg Tablet
Closent-0.25 MD Tablet
Gabasent-NT Tablet
Glimsentro-M1 Tablet SR
Glimsentro-MV2 Tablet SR
Parosen 25mg Tablet
Rozsentro Gold Capsule
Telsentro 80 Tablet
Telsentro-CT Tablet
Torsent 10 Tablet
Amisen 10 Tablet
Amisen 25mg Tablet
Cilsent-Trio Tablet
Glimsentro M2 Tablet PR
Metsentro-T25 Tablet
Metsentro-T50 Tablet
Rozsen 20 Tablet
Rozsen-F Tablet
Vildasentro M 50 Tablet
Closent-0.5 MD Tablet
Divzsen 250mg Tablet
ES Sentro 10 Tablet
Glimsentro-MV1 Tablet SR
Glimsentro-PG1 Tablet SR
Glimsentro-PG2 Tablet SR
Glipsentro 10 Tablet
Rozsen AS 75 Capsule
Sitasentro-M50 Tablet
Cilsent 10 Tablet
Cipsen 10mg Tablet
Cipsen 40mg Tablet
Clopsent-A Capsule
ES Sentro-Plus Tablet
Parosen 12.5mg Tablet
Rozsen 10 Tablet
Telsentro 20 Tablet
Telsentro 40 Tablet
Telsentro AM Tablet
Torsent Plus Tablet
Voglisentro 0.3 MD Tablet

Sentro Group has a reputation for providing innovative, high-quality solutions to customers
around the world. The company's commitment to customer satisfaction, along with its expertise in cuttingedge technologies, makes it a trusted partner for businesses in a wide range of industries.

For more information about Sentro Pharma and other solutions from Sentro Group, please visit thecompany's website at https://www.sentrogroup.com/

###

space

Other Related Press Releases